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Introduction
Citrus tristeza virus (CTV, genus Closterovirus,
family Closteroviridae) is the largest member of
its taxonomic family. Viral particles, 2000 nm in
length and 10–12 nm in diameter, are present in
the phloem of infected plants. A single stranded
positive sense RNA molecule approximately
20,000 nucleotides long constitutes its genome
(Bar-Joseph et al., 1985). This nucleic acid mole-
cule is encapsidated by the coat protein (CP),
which has a molecular mass of 25 kDa (Sekiya et
al., 1991). Another protein with a molecular mass
27 kDa (p27) (Febres et al., 1996) is also associat-
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ed with CTV virions (Febres et al., 1996). Devel-
opment of disease symptoms is dependent on the
combination of virus strains and hosts. CTV in-
fection has led to the decline and death of mil-
lions of citrus trees mostly grafted on sour orange
rootstocks (Bar-Joseph et al., 1985). Decline may
be in certain cases quick but slow decline for
months or years is most frequent. Strains respon-
sible for quick decline or stem pitting symptoms
on sweet orange are usually designated as severe
strains. Those that do not cause the mentioned
symptoms are referred to as mild strains.
As the control of the disease is based on early
CTV diagnosis, efforts must be made to develop
efficient and rapid diagnostic methods. Large-
scale diagnosis based on ELISA and immunoblot-
ting tests requires large amounts of antibodies.
Monoclonal antibodies may be more sensitive and
allow, as in the case of MCA13 for example (Per-
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mar et al., 1990), discrimination between severe
and mild strains from Florida. However, the risk
of the appearance of strains that lack an epitope
previously thought to be conserved is real (Kano
et al., 1991) and may give rise to false negatives
when monoclonal antibodies are used. Thus, pol-
yclonal antibodies or mixtures of monoclonal an-
tibodies seem more appropriate for broad-spec-
trum detection of the virus.
Raising polyclonal antibodies requires large
amounts of purified virions to be used in immuni-
zation procedures. In addition, the antigen may
not maintain its characteristics along successive
purifications. The use of CTV coat protein ex-
pressed in and purified from an Escherichia coli
system to raise polyclonal antibodies overcomes
these limitations, and avoids the production of
antibodies against host proteins that may be
present in the viral preparations (Nikolaeva et al.,
1996). Production of antisera against bacterially
expressed CTV coat protein (rCP-CTV) has been
previously described (Manjunath et al., 1993,
Nikolaeva et al., 1995, Bar-Joseph et al., 1997).
However these antisera could not be used as the
sole source of antibodies to detect CTV in ELISA
tests, due to their low efficiency for trapping the
virus. To overcome this problem an alternative but
complex immunisation scheme combining the use
of rCP-CTV and partially purified virus particles
was described by Bar-Joseph et al. (1997). In this
paper we describe the production of immunorea-
gents to detect a broad spectrum of CTV strains




The CTV isolates (see Table 1) used in this work
were obtained from Reunion Island, Spain and
Portugal (mainland and the Island of Madeira)
and Morocco (Zemzami et al., 1999). The virus iso-
lates were propagated by grafting infecting ma-
terial onto sweet orange (Citrus sinensis cv. Mad-
ame Vinous) and Mexican lime (Citrus aurantifo-
lia) plants. These were maintained in an insect
proof greenhouse which was kept under 30°C and
35°C in winter and summer seasons respectively.
Mild and severe symptoms were observed due to
infection with different strains within this collec-
Table 1. ELISA values of samples from diverse origins
maintained in collection or obtained in the field, tested













































a Bracketed values indicate the results obtained with a com-
mercial kit (Bioreba).
b Field samples. The readings of the negative controls ranged
from 0.1 to 0.2 and were previously subtracted. The status of
the negative samples was confirmed by IC/RT-PCR.
c M (mild), typical symptoms observable on Mexican Lime. SP
(stem-pitting), stem pitting in branches of Madam Vinous
sweet orange.
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tion (Table 1). Additional uncharacterised isolates
were collected in the field.
Isolation, amplification and cloning of the coat
protein gene
The CTV virions of the mild isolate of Spanish
origin CTV-19 were directly isolated from an in-
fected plant by immunocapture and the coat pro-
tein gene amplified as described by Nolasco et al.
(1993). The immunocapture was carried out using
IgG from a commercial CTV detection kit (Biore-
ba, Reinach, Switzerland). The primers used to
amplify the whole CP gene by PCR were based on
the Genbank accession  M76485 and had the fol-
lowing sequences: CTV10 (reverse primer): 5'-AT-
CAACGTGTGTTGAATTTCC-3' and CTV1 (for-
ward primer): 5'- ATGGACGACGAAACAAAGAA-
3'. The PCR products were TA-cloned in the pCRII
vector (TA cloning system – Invitrogen, Groningen,
The Netherlands) according to the manufacturer’s
instructions. For expressing purposes the insert
was transferred to the pTrcHisA vector (Invitro-
gen) and sequenced to verify the correct in frame
insertion, according to standard procedures (Sam-
brook et al., 1989). The pTrcHisA-19.21 construc-
tion was used to transform TOP 10 E. coli cells
(Invitrogen).
Expression and purification of recombinant coat
protein
For the preparative scale production of the re-
combinant protein a 60 ml E. coli culture in SOB
medium (2% Bacto-tryptone, 0.5% Bacto-yeast ex-
tract, 10 mM NaCl, 2.5 mM KCl) medium contain-
ing ampicillin was grown at 37°C and induced with
1 mM isopropyl-thio-β-D-galactoside (IPTG) when
bacterial culture density reached OD600 = 0.6. The
cells were harvested at 5 h after induction, pellet-
ed and resuspended in 12 ml of guanidinium lysis
buffer (6 M guanidine hydrochloride, 20 mM sodi-
um phosphate, 500 mM sodium chloride, pH 7.8),
ultra sonicated on ice and the insoluble debris elim-
inated by centrifugation at 13,200 g for 5 min. The
fusion protein was purified from the lysate by metal
affinity chromatography in Ni+ ProBond columns
(Invitrogen) according to the manufacturer’s in-
structions. Partially purified fusion protein was
dialysed against 10 mM Tris (pH 8.0) containing
0.1% Triton X-100, quantified by the Bradford
method (Bradford, 1976) and analysed by denatur-
ing SDS-PAGE (15%) on Tris-glycine (pH 8.3) buffer
and Western blotting according to standard meth-
ods (Laemmli, 1970; Ausubel et al., 1990). The fi-
nal purification of the fusion protein was achieved
by cutting the band from a preparative SDS-PAGE
(15%) gel.
Immunization, production and conjugation of
polyclonal antibodies
Two rabbits were immunized with the purified
fusion protein (crushed polyacrilamide gel band
containing the protein) by a specialised firm (Eu-
rogentec, Saraing, Belgium). The immunization
scheme consisted of antigen injections on days zero,
14, 28 and 56, with 35 µg of protein per injection.
Bleedings were done at days 38 (2 ml), 66 (22 ml)
and 80 (50 ml). The antiserum obtained from the
last bleeding of rabbit B (designated AS 19-21) was
purified by affinity chromatography on a protein
A-sepharose column. Part of the IgG thus obtained
was biotinylated by incubation with N-hydroxy-
succinimidobiotine (5:1, w:w) at 25°C for 2 hours
followed by dialysis against PBS (pH 7.4).
Immunoenzymatic-assay procedures
Standard ELISA procedures were used. Plant
extracts were obtained as previously described
(Bar-Joseph et al., 1979). All the assays were con-
ducted in microtiter plates (ref. 650161 Greiner-
Labortechnik GmbH, Frickenhausen, Germany)
using 100 µl per well of reagents. Absorbance read-
ings of samples were recorded at 405 nm (A405) in a
Titerteck Multiscan reader without previous sub-
traction of blanks. The A405 values presented in the
results are the mean of two replicates or three rep-
licates in the case of the negative controls. The
mean A405 value of the negative controls was sub-
tracted from the mean value of the samples before
plotting the data. The positive/negative threshold
was fixed as 6,965 times the standard deviation
(corresponding to a 99% confidence level in a one-
tailed T distribution). Indirect double antibody
sandwich ELISA (IDAS-ELISA) was used to test
the detecting ability of antisera and purified IgG.
Thus microtiter plates were coated with a mixture
of CTV specific monoclonal antibodies (3DF1+3CA5)
obtained from Ingenasa (Valencia, Spain) diluted
1:1000 and the antibodies from AS 19-21 were de-
tected with an alkaline phosphatase anti-rabbit
IgG conjugate (Sigma A-3687, Sigma Aldrich, St.
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Louis, USA) diluted 1:10,000. The trapping abili-
ty of the purified IgG in the coating step was also
assayed by IDAS-ELISA. In this case plate coat-
ing was done with IgG from AS 19-21 at (1 µg ml-
1) and detection was achieved by monoclonal an-
tibodies (3DF1+3CA5) diluted 1:10,000, followed
by an anti-mouse IgG alkaline phosphatase con-
jugate diluted 1:10,000. The biotinylated kits pre-
pared with IgG from AS 19-21 were used in the
following conditions: plate coating carried out for
3h at 37°C with 1 µg / ml of AS 19-21 IgG, fol-
lowed by overnight incubation with viral antigens
at 4°C, incubation with biotinylated-IgG diluted
1:1,000 for 3 h at 37°C, incubation for 1 h at 37°C
with ExtrAvidin alkaline phosphatase conjugate
(Sigma E-2636) diluted 1:8,000. Comparisons
were done with a commercial kit to detect CTV
from Bioreba following the instructions enclosed,
but using volumes of 100 µl of reagents per well.
Immunodot blot and immunotissue print proto-
cols were based on Garnsey et al. (1993) using ni-
trocellulose membranes (45 µm) which had been
previously moistened with PBS. Blocking was
done with 5% low fat milk solution. Detection was
done with crude AS 19-21 antiserum (1:10000 di-
lution). Detection of immobilised AS 19-21 anti-
bodies was carried out by goat IgG raised against
anti-rabbit IgG conjugated with alkaline phos-
phatase (1:10,000 dilution). A pre-made solution
of 4-nitroblue tetrazolium chloride and 5-bromo-
4-chloro-3-indolyl-phosphate (BCIP-NBT, Roche
1681451Basel, Switzerland) was used as phos-
phatase substrate.
Results
Expression and purification of the recombinant
CTV coat protein
In preliminary experiments no novel peptide
band of the correct size (about 28 KDa as expect-
ed for the fusion of the CTV-CP plus the leader
sequence of the expression vector) could be detect-
ed by SDS-PAGE analysis in the bacterial culture
medium or in the soluble fraction after induction
of expression of the pTrcHisA-19.21. However,
analysis of the insoluble fraction showed a new
band of the correct size, which became stronger
with increasing growth times. The specificity of
this band was demonstrated by Western blot anal-
ysis with 3DF1+3CA5 monoclonal antibodies. As
the intensity of this specific band was weak, al-
ternative conditions of induction (0.3 mM IPTG)
and bacterial growth (24°C) were assayed but no
better results were obtained (Fig. 1). Preparative
expression of the recombinant CTV coat protein
was then done under the conditions described in
the Materials and methods. The protein yield af-
ter affinity chromatography was 9.6 mg per litre
of cell culture. However SDS-PAGE analysis of the
affinity chromatography eluate still showed the
presence of additional contaminant proteins of
higher molecular mass, thus reducing the specif-
ic rCP-CTV yield. The rCP-CTV could be identi-
fied in this preparation by western blot analysis
with 3DF1+3CA5 monoclonal antibodies, migrat-
ing as an isolated band (Fig. 1).
Performance of the antisera as detecting antibodies
Indirect ELISA assays were done to study the
performance of the antisera and purified IgG as
detecting antibodies (Fig. 2). Crude antisera from
both rabbits (final bleeding) demonstrated a very
good detecting ability of the virus in extracts of
infected plants. An antisera dilution of 1:80,000
still produced a difference of about 1.5 absorban-
cy units between infected and healthy samples.
Purified IgG at the same dilution (from a 1 mg
ml-1 stock) also showed positive results but the
absorbancy was very close to the discriminating
positive/negative threshold. Similar results were
obtained with a few CTV isolates. In comparative
assays the IgG from the Bioreba kit could not de-
tect the virus at dilutions higher than 1/40,000.
A parallel assay was done with the rCP-CTV
(1 µg ml-1) purified according to the Materials and
methods instead of infected plant sap. In this case,
the antigen could barely be detected by the crude
antisera. Purified IgG from our serum or from Bi-
oreba also failed to detect it (data not shown).
The ability to detect membrane bound CTV vir-
ions was tested by immunotissue printing and dot
blot tests (Fig. 3). There was a clear distinction
between imprints of healthy and of infected sam-
ples. These assays allowed the detection of CTV
isolates from Reunion Island, Portugal (main-
land), Spain and the Island of Madeira.
Performance as trapping antibodies
The performance of the AS 19-21 IgG for trap-
ping the antigen in the coating step was assayed
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Fig. 1. Analysis by SDS-PAGE (15%) and Western blot of cellular extracts of Escherichia coli cultures harbouring
the expression vector pTrcHisA 19-21. Panel A) SDS PAGE (15%) analysis of cellular extracts of cultures grown at
37°C (lanes 1 to 5) and 24°C (lanes 6 to 9). Lane 1, time 0, expression not induced. Lanes 2 and 3, respectively, 3 h
and 5 h after induction with 0.3 mM IPTG. Lanes 4 and 5, respectively, 3 h and 5 h after induction with 1 mM IPTG.
Lanes 6 to 9, same time and concentration of IPTG as in lanes 2 to 5. M,  molecular marker, LMW (Pharmacia LKB
Biotechnology, Sweden) with indicated molecular mass in KDa. Coomassie blue staining. Panel B) Western blot
analysis of a twin gel of panel A. Panel C) SDS PAGE (15%) analysis of purified (lane 1) and unpurified (lane 2) rCP-
CTV. The arrow indicates the position of the band that was used as immunogen.
Fig. 2. Detecting ability of antisera and IgG produced against bacterially expressed CP in IDAS-ELISA. AS 19-21 A
and B - crude antisera from two rabbits A and B tested against infected (isolate CTV 19) plant sap. AS 19-21 IgG -
immunoglobulin purified from AS 19-21 B, tested against infected (isolate CTV 19) plant sap. Bioreba IgG - immu-
noglobulin from a commercial kit, tested against infected (isolate CTV 19) plant sap. rCP - antisera AS 19-21 A,
tested against the purified recombinant protein (1 µg ml-1). The dilutions at which the antisera were assayed are
indicated. Absorbancy readings were done after 30 minutes of incubation with the enzyme substrate. The values
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by IDAS-ELISA using extract of plants infected with
a Spanish CTV isolate. A parallel assay was con-
ducted with IgG from Bioreba. Both sources of IgG
gave similar values of absorbancies (differences of
infected and healthy controls were around 1 unit
after 45 min. of incubation with the substrate). The
ability of the immunoglobulin to immunocapture
diverse CTV isolates in IC/RT-PCR was also assayed
in comparison with direct adsorption of virions on
uncoated tubes. A clear increase in intensity of the
band was obtained when the tubes were previously
coated with the AS 19-21 IgG (data not shown).
Use of AS 19-21 IgG in DAS ELISA kits
In view of its good ability for trapping and de-
tecting the virus, AS 19-21 IgG was used as the
sole source of antibodies to produce a diagnostic
kit. After optimisation, the kit was assayed with
selected isolates from diverse origins (Table 1). The
performance of this kit was equivalent to an ELI-
SA kit of commercial origin (Bioreba), and in addi-
tion it also detected a broad spectrum of CTV iso-
lates. These characteristics have permitted its use
as part of a CTV eradication programme currently
being conducted in Portugal.
Fig. 3. Detection of membrane bound virions. Panel A: immunodot assay with diverse field samples from Reunion
Island; negative controls are in column C, rows 1 and 2. Panel B: immunotissue prints of sections of healthy (column
A) and infected (columns B and C) sweet orange stems. Amplified imprints of samples 3A and 2C show the difference
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Discussion
The purpose of this work was to produce immu-
noreagents for an ELISA kit that could be used for
routine diagnosis of CTV in Portugal. The major
source of the disease is still the infected budwood
illegally introduced from Spain, but there is now
the risk of introduction of severe strains from the
Island of Madeira (Nolasco et al., 1998). The het-
erogeneity of CTV strains makes it useful to have
broad-spectrum antibodies available that could
detect exotic strains. The disadvantage of gener-
ating antigen by expressing the coat protein gene
is the risk of expressing a clone corresponding to a
rare variant of the virus. On the other hand, this
strategy offers additional possibilities of selecting
(or even trimming) the amino acid sequence.
The yield of the expressed recombinant CP in
our system was very low (less than 10 mg l-1) as
compared to 100 mg or 280 mg per litre obtained by
Nikolaeva et al. (1995) and Manjunath et al., (1993)
respectively, for a fusion protein containing the CP
of CTV, although these authors used different sys-
tems for expressing the recombinant protein. At-
tempts to improve the yield by using a sub-optimal
temperature for the culture growth were unsuccess-
ful. However in the present study a higher yield
proved to be unnecessary. In fact, the recombinant
protein that was obtained from a 60 ml culture was
sufficient for the immunization of two rabbits.
The performance of the AS 19-21 antibodies at
the detecting stage of IDAS-ELISA was good as
assessed in comparative tests conducted with poly-
clonal antibodies from a commercial kit (Bioreba).
Good performance was also obtained when used
as detecting antibodies in antigen-membrane
bound techniques, with isolates from diverse ori-
gins. This is in accordance with the results from
other authors (Manjunath et al., 1993; Nikolaeva
et al., 1995, 1996; Pappu et al., 1995), who have
shown that the antibodies produced against an E.
coli expressed recombinant CTV-CP perform well
as detecting antibodies. However, it is generally
accepted that this kind of approach is not adequate
to produce good trapping antibodies. This would
rule out the possibility of producing diagnostic kits
based solely on a single antibody source. The rea-
sons for the usually poor trapping ability of such
antibodies are not fully understood. It has been
suggested that antibodies produced against recom-
binant proteins recognise sequential epitopes rath-
er than conformational ones. This would be due to
the incorrect folding of the bacterial expressed pro-
tein. Bar-Joseph et al. (1997) were able to over-
come this drawback by using an immunization
scheme in which the primary injection was carried
out with the recombinant protein and the booster
injection with a partially purified preparation of
CTV. However our results clearly showed that our
antibodies could successfully be used at the trap-
ping stage of ELISA or IC/RT-PCR experiments.
In addition, there are reports (Vaira et al., 1996)
with other viruses showing that antibodies against
expressed proteins may have good ability to trap
the viral antigens. These characteristics enabled
us to prepare an efficient diagnostic kit that is
based solely on a single antiserum produced
against the expressed protein. These reagents are
now routinely used for CTV screening in Portugal.
It is intriguing however that the same protein
preparation that was used as immunogen could be
barely detected in IDAS-ELISA using the homolo-
gous antibodies. The reasons for this were not fur-
ther investigated. It was suggested that the fusion
protein, following purification and with the effect
of time and storage, could acquire a different con-
formation, hiding the reacting epitopes. These are
most probably sequential, since the immunisation
was done with a denaturing SDS-PAGE purified
protein band. Such a conformation is perhaps more
stable than the native conformation of the viral
CP, which would allow a partial denaturation ex-
posing sequential epitopes. In western blot analy-
sis the rCP-CTV may be detected because it is also
denatured. From a practical point of view, this char-
acteristic prevents the use of the rCP-CTV as a
positive control for ELISA, which could be impor-
tant in countries where CTV has not yet been de-
tected. In these cases lyophilised bark from twigs
of infected plants could be used.
Since the expression plasmids can be stored for
long periods, the production of bacterial expressed
viral proteins is a good strategy to provide uniform
immunogens for antibody production as it avoids
laborious virus purification methods and the need
for expensive equipment.
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